Amazon to buy PillPack in potentially disruptive drug retail push
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Walgreens Boosts Alliance (WBA) PT Lowered to $64 at Evercore ISI; Today was a 'Complete Mess', But Maintaining OP Rating
June 28, 2018 11:51 AM EDTEvercore ISI lowered its price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $64.00 (from $74.00) while maintaining an Outperform rating.
Analyst Ross Muken commented, "What a complete mess today turned out to be (and here I was worried about balancing MCKs Analyst Day w/ WBAs report). While on the surface WBAs print... More
Buy CVS Health (CVS) and Express Scripts (ESRX) on Amazon/PillPack Deal Weakness - Mizuho
June 28, 2018 11:47 AM EDTMizuho analyst Ann Hynes said they would be buyers of CVS Health (NYSE: CVS) and Express Scripts (NASDAQ: ESRX) amid weakness related to Amazon's purchase of PillPack.
Hynes said the bark of the deal is likely worse than the bite, at lease initially. "Obviously from a multiple perspective, this announcement will weigh on valuation. From an earnings and cash flow perspective, that impact is less clear and our initial thoughts is market share gains will be limited, at least in the intermediate-term. We confirmed... More
McKesson (MCK) Reaffirms FY19 Guidance, Preliminary Guidance for Q1 Tops Views
June 28, 2018 9:06 AM EDTMcKesson Corporation (NYSE: MCK) today reaffirmed its Adjusted Earnings per diluted share guidance of $13.00 to $13.80 for the fiscal year ending March 31, 2019, and the underlying key assumptions provided in its press release on May 24, 2018. The company also anticipates Adjusted Earnings per diluted share of approximately $2.85 to $2.95 for the first quarter of Fiscal 2019.
(Street sees Q1 EPS of $2.69)
McKesson is hosting its Investor Day today in Boston, Massachusetts. A webcast of the presentation is available through McKessons website,... More
